This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells
Leukemia Open Access 17 March 2021
-
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
Nature Communications Open Access 12 February 2021
-
Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency
Leukemia Open Access 18 June 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wlodarski MW, Hirabayashi S, Pastor V, Stary J, Hasle H, Masetti R et al. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood 2016; 127: 1387–1397, quiz 518.
Babushok DV, Bessler M, Olson TS . Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults. Leuk Lymphoma 2016; 57: 520–536.
Shannon KM, Turhan AG, Chang SS, Bowcock AM, Rogers PC, Carroll WL et al. Familial bone marrow monosomy 7. Evidence that the predisposing locus is not on the long arm of chromosome 7. J Clin Invest 1989; 84: 984–989.
Carroll WL, Morgan R, Glader BE . Childhood bone marrow monosomy 7 syndrome: a familial disorder? J Pediatr 1985; 107: 578–580.
Sakaguchi H, Okuno Y, Muramatsu H, Yoshida K, Shiraishi Y, Takahashi M et al. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet 2013; 45: 937–941.
Faber ZJ, Chen X, Gedman AL, Boggs K, Cheng J, Ma J et al. The genomic landscape of core-binding factor acute myeloid leukemias. Nat Genet 2016; 48: 1551–1556.
Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J . A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 2014; 46: 310–315.
Narumi S, Amano N, Ishii T, Katsumata N, Muroya K, Adachi M et al. SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7. Nat Genet 2016; 48: 792–797.
Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 2013; 122: 3616–3627, quiz 99.
Al Seraihi A, Rio-Machin A, Tawana K, Bödör C, Araf S, Heward J et al Penetrance is Linked with Monoallelic Gene Expression in Inherited GATA2-Mutated MDS/AML. American Society of Hematology 58th Annual Meeting and Exposition. 2016, San Diego, CA, USA.
Chen DH, Below JE, Shimamura A, Keel SB, Matsushita M, Wolff J et al. Ataxia-Pancytopenia syndrome is caused by missense mutations in SAMD9L. Am J Hum Genet 2016; 98: 1146–1158.
Li FP, Hecht F, Kaiser-McCaw B, Baranko PV, Potter NU . Ataxia-pancytopenia: syndrome of cerebellar ataxia, hypoplastic anemia, monosomy 7, and acute myelogenous leukemia. Cancer Genet Cytogenet 1981; 4: 189–196.
Tesi B, Davidsson J, Voss M, Rahikkala E, Holmes TD, Chiang SC et al. Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS and neurological symptoms. Blood 2017; 129: 2266–2279.
Nagamachi A, Matsui H, Asou H, Ozaki Y, Aki D, Kanai A et al. Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7. Cancer Cell 2013; 24: 305–317.
Wong JC, Weinfurtner KM, Alzamora Mdel P, Kogan SC, Burgess MR, Zhang Y et al. Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis. elife 2015; 4: e07839.
Acknowledgements
We thank the family in this study and for the clinical staff involved in their care and management. We thank Tina Motroni for BM histology images and the Hartwell Center at SJCRH for providing sequencing assistance. This work was funded in part by the American Lebanese and Syrian Associated Charities (ALSAC) of SJCRH and the US National Institutes of Health (K08 HL116605-JMK). JMK holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Rights and permissions
About this article
Cite this article
Schwartz, J., Wang, S., Ma, J. et al. Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome. Leukemia 31, 1827–1830 (2017). https://doi.org/10.1038/leu.2017.142
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2017.142
This article is cited by
-
Pediatric Germline Predisposition to Myeloid Neoplasms
Current Hematologic Malignancy Reports (2022)
-
Advances in germline predisposition to acute leukaemias and myeloid neoplasms
Nature Reviews Cancer (2021)
-
Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells
Leukemia (2021)
-
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
Nature Communications (2021)
-
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes
Nature Medicine (2021)